% | $
Quotes you view appear here for quick access.

Neuralstem, Inc. Message Board

  • guanakeymelqendi guanakeymelqendi Mar 5, 2013 11:35 AM Flag

    FDA seeking comments on ALS

    I'm sure the FDA would appreciate our comments on their latest ALS Hearing. (Search for FDA ALS hearing and reply to Docket No. FDA-2013-N-0035.) I tried not to be too negative but how optimistic can you be when the average life expectancy for an ALS patient is 3-5 years and it takes 10 years to push a new therapy or drug through all the hoops. Three lifetimes seems like a long time to make patients wait.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.256-0.0034(-1.31%)Jul 22 3:59 PMEDT